Home / News Center / ALPHA Launches its new anti-hypertinsive drug DIVOLTAN
ALPHA Launches its new anti-hypertinsive drug DIVOLTAN
Date: 2011-09-07
Dr. AbdulRazzakd Kadour was the guest speaker in addition to Dr. Walid Bsata, who was the chairman of the lecture.
Guests included Cardiologists, Internists, Endocrinologists, and other specialities.
ALPHA has once again played the role of pioneer as we are proud to be the first Syrian Pharmaceutical Company to launch this latest generation combination drug to treat hypertension.
DIVOLTAN's launch is another step in ALPHA's commitment to continously play a pivotal and important role in the advancment of Syria's Health Sector by offering our doctors and patients the very latest and safest in the world of anti-hypertensives.
After the lecture, which lasted for one hour, guests were invited to Sheraton's spectacular outoor court for dinner and drinks.
